Visugromab,Nivolumab
BMS,Catal ym
['mibc', 'congrat', 'neo-gdfather', 'solid tumor', 'gdfather', 'catalym']
#gdf-15 #visugromab development is a promising challenge in io-refractory solid tumors. congrats ignacio melero &amp; #catalym team! neo-gdfather trial in #mibc opening soon in #asco23 
Associate Professor @MyUniSR - Head of Genitourinary Medical Oncology @SanRaffaeleMI - Vice President @GTumors